Latest Platform Providers News

Sequoia Financial Group faces a pivotal shift as HUB24 stops accepting new business from its InterPrac Financial Planning advisers, prompting a strategic transition for the company’s adviser network.

Sequoia Financial Group is actively reviewing its retail licensee services, focusing on its subsidiary InterPrac Financial Planning, with potential structural changes or a sale under consideration amid shifting platform provider relationships.

Vitura Health has inked a binding distribution agreement with MedReleaf Australia, unlocking access to a broad medicinal cannabis portfolio across its extensive pharmacy network. This deal could add up to AUD 15 million annually, positioning Vitura as a dominant player in the evolving Australian market.

Hubify has provided detailed terms of its $250,000 equity investment in Australian AI firm HubLab, reinforcing its AI-first growth ambitions targeting enterprise and government sectors.

KneoMedia Limited reported a half-year loss of $1.02 million for H1 FY26, impacted by delayed payments from New York City amid a mayoral transition. The company is preparing for ASX reinstatement and a $3 million capital raise to support growth.

TZ Limited reported a $1.92 million loss for the half-year ending December 2025, with revenues of $5.4 million impacted by delayed US projects and integration challenges from its Keyvision acquisition. The company is banking on large tenders and expanding Microsoft data centre sales to drive recovery.

Stanmore Resources delivered record coal production and strong cash flow in 2025 despite softer market prices, declaring a fully franked dividend and guiding a modest production decline for 2026.

Wrkr Ltd reports a 43% revenue increase to nearly $7 million in H1 FY2026 but also a 75% rise in net loss, while completing a $15 million capital raise and acquiring payroll compliance firm PaidRight.

EZZ Life Science Holdings has secured a four-year exclusive global distribution agreement with Aumake Limited, committing to at least A$10 million in purchases. This partnership aims to accelerate EZZ’s international reach while preserving brand control.

Macquarie Group reports solid 3Q26 results with robust profit growth across divisions and a strong capital surplus, underpinned by strategic technology investments and regulatory compliance.

Imricor Medical Systems has taken a significant step toward US market entry by submitting its Advantage-MR EP Recorder/Stimulator system for FDA 510(k) clearance, aiming to enhance MRI-guided cardiac procedures.

EPX Limited has secured Wattwatchers Pty Limited through a Deed of Company Arrangement, backed by a $2.14 million placement and a Share Purchase Plan to raise additional funds. This strategic move enhances EPX’s energy monitoring capabilities and recurring revenue streams.